Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles.
Saved in:
| Title: | Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles. |
|---|---|
| Authors: | Sipes J; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.; Bioengineering Program, The University of Kansas, Lawrence, Kansas., Zha D; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois., Rayamajhi S; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas., Bantis LE; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas.; The Kansas Institute for Precision Medicine, University of Kansas Medical Center, Kansas City, Kansas., Madan R; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas., Mitra A; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas., Puri RV; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas., Rahman MM; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas., Ahmmed F; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas.; Department of Statistics, Comilla University, Cumilla, Bangladesh., Pathak HB; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.; The Kansas Institute for Precision Medicine, University of Kansas Medical Center, Kansas City, Kansas., Russo A; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois., Sardiu M; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas., Isenberg BC; Charles Stark Draper Laboratory, Cambridge, Massachusetts., Cain BP; Charles Stark Draper Laboratory, Cambridge, Massachusetts., Coppeta J; Charles Stark Draper Laboratory, Cambridge, Massachusetts., Galhenage PM; Center for Personalized Cancer Therapy, University of Massachusetts, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts., Pathania S; Center for Personalized Cancer Therapy, University of Massachusetts, Boston, Massachusetts.; Department of Biology, University of Massachusetts Boston, Boston, Massachusetts., David SM; Translational Oncology Program, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, Illinois., Burdette JE; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.; Bioengineering Program, The University of Kansas, Lawrence, Kansas.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas.; The Kansas Institute for Precision Medicine, University of Kansas Medical Center, Kansas City, Kansas. |
| Source: | Cancer research communications [Cancer Res Commun] 2025 Aug 01; Vol. 5 (8), pp. 1266-1281. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
